Skip to main content

This job has expired

Research Associate in Polymer Nanoparticles

Manchester, United Kingdom
£32,236 - £35,211 per annum according to relevant experience.
Closing date
4 Mar 2019

View more

Academic Discipline
Physical Sciences, Chemistry
Job Type
Research Related, Research Associate
Contract Type
Fixed Term
Full Time

Job Details

Location : Oxford Road, Manchester
Closing Date : 18/03/2019
Salary : £32,236 - £35,211 per annum according to relevant experience.
Employment Type : Fixed Term
Faculty / Organisational Unit : Science & Engineering
Division : Chemistry
Hours Per week : Full time
Contract Duration : From as soon as possible for 12 months

This is a fantastic opportunity to take part in a new and innovative project to develop a novel biomedical imaging platform that could change the way we manage endometrial cancer, specifically by improving risk prediction for development of endometrial cancer.

Endometrial cancer (EC), of all cancers, has the strongest association with obesity, estimated to account for 60% of new cases, as a consequence of which the incidence of EC is rising sharply in post-menopausal women. Outcome is much improved with early detection, leading to high numbers of women with post-menopausal bleeding (PMB), the main symptom of EC, undergoing endometrial biopsy to determine if early cancer is present. However, negative biopsy does not preclude development of EC at a later date, leading to high degree of uncertainty for those with negative biopsies. Colleagues at St Mary’s Hospital Manchester have developed a prototype biomarker method for prediction of future risk of EC in women with negative biopsies, measuring the expression of 4 cell markers in endometrial biopsies. At present each of these markers is measured independently but it would be advantageous to measure them simultaneously. This requires a multiplex approach which this project seeks to develop and test. Specifically we have developed novel fluorescent tags for antibodies which will allow the 4 biomarkers to be measured simultaneously in endometrial biopsies and this project seeks to optimise their use in prediction of risk of EC in negative endometrial biopsies. This will require optimisation of antibody / fluorescent tag conjugation, multiplex staining and imaging, and analysis of biomarker expression and correlation with clinical parameters. The end product will be a validated semi-automated method for risk prediction of EC in post-menopausal women. This is a large and growing public health problem, whilst methods developed will also be transferable to cancer diagnosis across all cancers. This post is a SBRI award to Chromition and provides the opportunity to work within our existing team of clinicians, biomedical and computer scientists.

We are looking for a post-doctoral researcher with experience of organic chemistry, polymer nanoparticles and antibody conjugation. The post holder will responsible for development of novel nanoparticle / antibody conjugates, liaising with the academic team work, including clinical academics in pathology and gynaecological oncology, chemists at the University of Manchester (UoM) and Chromition (a UoM spin-out company), senior computer scientists based within the University of Manchester, and with imaging scientists at CRUK-Manchester Institute. Knowledge of cancer treatment would be useful but is not essential as the team has extensive expertise in this area.

The School of Chemistry is strongly committed to promoting equality and diversity, including the Athena SWAN Charter for gender equality in higher education. The School holds a Silver Award which recognises their good practice in relation to gender; including flexible working arrangements, family-friendly policies, and support to allow staff to achieve a good work-life balance. We particularly welcome applications from women for this post. Appointment will always be made on merit. For further information, please visit

We positively welcome applications from women, who are currently under-represented at this grade. Appointment will be made on merit.

You may also be interested in the following vacancies;

BMH-13488 Research Associate in Digital Pathology

BMH-13491 Research Technician

Please note that we are unable to respond to enquiries, accept CVs or applications from Recruitment Agencies

Enquiries about vacancy shortlisting and interviews:

Professor Mike Turner and Dr Richard Byers. richard.byers@cmft.nhs.

Technical support:


Tel: 0161 850 2004

General enquiries:


Tel: 0161 275 4499

This vacancy will close for applications at midnight on the closing date

Further Particulars and Job Description



Following a 2.5million donation by Greensill, a leading British FinTech company founded by Lex Greensill, Alliance Manchester Business School at The University of Manchester is looking to recruit to three brand new posts! These appointments will have an emphasis on Financial Technology and be part of the School’s strategy to strengthen research and teaching on the topic and boost the region’s capacity and capability in Financial Technology (FinTech).

It is an exciting time to be based in Greater Manchester, one of Europe’s leading digital and technology clusters. The region is home more fintech start-ups and scale-ups than any other UK region outside London, and Manchester was the fastest growing tech city in Europe in 2019.

Company info
M13 9PL

Get job alerts

Create a job alert and receive personalised job recommendations straight to your inbox.

Create alert